The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Spravato, a newly FDA-approved nasal spray, offers hope for individuals with treatment-resistant depression, a condition ...

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

A nasal spray of oxytocin significantly reduced acute ... instead of providing relief. “We used to think this is the kind of hormone that always makes people feel good and happy, and that ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment ... which can often take weeks to provide relief for those suffering from depression.” ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...

Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...